| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 14, 2011Medtronic Pledges Action in Advance of United Nations High Level Meeting on Noncommunicable DiseasesThe World's Leading Medical Technology Company Pledges Resources to Improve Healthcare Systems and Access to Therapies in Lower- and Middle-Income Countries
MINNEAPOLIS, Sep 14, 2011 (BUSINESS WIRE) -- In a continued mission to reduce the global burden of noncommunicable diseases (NCDs) such as cardiovascular disease and diabetes, Medtronic, Inc....
-
Sep 12, 2011New technology offers one-source, customizable option for bone grafting space maintenance in oral-maxillofacial applications
MEMPHIS, Tenn., Sep 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced today the U.S. launch of its ARTISAN(TM) Space Maintenance System. The device is cleared for temporary use in...
-
Sep 8, 2011
MINNEAPOLIS, Sep 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global...
-
Sep 8, 2011Index Acknowledge Corporate Sustainability Accomplishments
MINNEAPOLIS, Sep 08, 2011 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
-
Aug 31, 2011Indicated for Endovascular Treatment of Abdominal Aortic Aneurysms, Medical Device Has Been Used to Treat More Than 6,000 Patients in United States Since December FDA Approval
MINNEAPOLIS, Aug 31, 2011 (BUSINESS WIRE) -- Leading the development of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT) today announced the start of its U.S. post-approval study of...